Recent Updates
Recently added Catalysts
KURA Positive Sentiment Score: 75/100

Kura Oncology to Participate in the JMP Securities Hematology and Oncology Summit

Tuesday, November 28, 2023 1 min read
Key Takeaway: Kura Oncology, a biopharmaceutical company focused on cancer treatment, announced its participation in the JMP Securities Hematology and Oncology Summit. Scheduled for December 5, 2023, the event will feature a virtual fireside chat with CEO Troy Wilson. Investors can access a live audio webcast through Kura's website, with a replay available afterward. This engagement underscores Kura's commitment to sharing insights on precision medicine in oncology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kura Oncology is participating in a noteworthy industry event.
  • Involvement in the JMP Securities Hematology and Oncology Summit highlights Kura's commitment to cancer treatment.
  • The virtual format allows widespread accessibility for investors and interested parties.

Full Press Release Details

SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the JMP Securities Hematology and Oncology Summit at 2:00 p.m. ET / 11:00 a.m. PT on Tuesday, December 5, 2023.
A live audio webcast of the presentation will be available in the Investors section of Kura’s website at www.kuraoncology.com, with a replay available shortly after the live event.
Executive Vice President, Investor Relations &
Corporate Communications
pete@kuraoncology.com
Alexandra Weingarten
Senior Manager, Corporate Communications
alexandra@kuraoncology.com

Tags

Frequently Asked Questions

When is Kura Oncology's virtual fireside chat?

The chat is scheduled for December 5, 2023, at 2:00 p.m. ET.

Who will represent Kura Oncology in the chat?

Troy Wilson, Ph.D., J.D., will participate as CEO.

Where can I watch the Kura Oncology presentation?

You can view it on Kura’s Investors section of their website.

Is there a replay available for the event?

Yes, a replay will be accessible shortly after the live event.

Tags: KURA Viatris Investor Conferences Healthcare hematology oncology biopharmaceutical precision medicine
Last updated: Nov 28, 2023